Navigation Links
NeurogesX Submits NDA for NGX-4010 Dermal Capsaicin Patch for Treatment of Postherpetic Neuralgia (PHN)
Date:10/22/2008

Marketing Application Submitted on Schedule

SAN MATEO, Calif., Oct. 22 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that it has submitted a new drug application (NDA) with the U.S. Food and Drug Administration (FDA) for approval to market its investigational product candidate, NGX-4010, for the management of pain due to postherpetic neuralgia (PHN). NeurogesX anticipates that the application, which is subject to acceptance by the FDA, will be subject to a standard review with a Prescription Drug User Fee Act (PDUFA) date in the second half of 2009.

NGX-4010, the Company's lead product candidate, is a dermal high-concentration capsaicin patch. The NDA submission is supported by two pivotal studies of NGX-4010 in patients with PHN. The results of these clinical trials show a statistically significant reduction in pain from baseline for up to 12 weeks after a single 60-minute application of the dermal patch. In these studies, NGX-4010 could be administered either as a monotherapy or in combination with other systemic neuropathic pain medications. The most common adverse reactions associated with NGX-4010 were redness, pain, and itching at the application site during and shortly after application. The NDA clinical package includes data on over 2300 patients with neuropathic pain.

Anthony DiTonno, President and CEO, commented, "Our top priority is to secure marketing approval of NGX-4010 in both the United States and Europe. With the submission of our NDA and the ongoing review of our Marketing Authorization Application in the European Union, from which we anticipate a decision in the first ha
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeurogesX Responds to EMEAs Day 120 Questions
2. NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference
3. NeurogesX Reports Second Quarter 2008 Results
4. NeurogesX to Report Second Quarter 2008 Financial Results
5. NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
6. NeurogesX to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
7. NeurogesX Reports First Quarter 2008 Results
8. NeurogesX to Report First Quarter 2008 Financial Results
9. NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference
10. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
11. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... NJ (PRWEB) , ... August 05, 2015 , ... ... that highlights the advantages of leveraging big data in pharmacovigilance. , Biopharmaceutical companies ... identify better targets, better design clinical trials, enable translational science, and better position products ...
(Date:8/5/2015)... , Aug. 5, 2015 The ... and Commerce Committee members Reps. Joe Barton ... as a delegation of 33 House members, for their ... , acting administrator for the Centers for Medicare & ... reimbursement in the CMS,s 2016 Medicare Physician Fee Schedule ...
(Date:8/5/2015)... 5, 2015 Global ... to reach USD 6.24 billion by 2022, according ... Inc. The Increasing demand for monoclonal antibodies and ... drive the cell line development industry over the ... Increasing prevalence of autoimmune diseases and ...
(Date:8/5/2015)... 2015  MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) ("MabVax" ... company, announces the posting of the following Letter to ... Hansen to the Company,s website at www.mabvax.com ... have invested in MabVax Therapeutics because you share our ... difficult cancers.  You also share our excitement about our ...
Breaking Biology Technology:New White Paper Explores How Big Data Enables Better Pharmacovigilance 2Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding 2Biosimilars Forum Applauds Reps. Barton, Eshoo for Leadership on Proposed Medicare Rule on Biosimilar Coding 3Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 2Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 3Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 4Cell Line Development Market To Reach $6.24 Billion By 2022: Grand View Research, Inc. 5MabVax Therapeutics Issues Letter to Stockholders 2MabVax Therapeutics Issues Letter to Stockholders 3MabVax Therapeutics Issues Letter to Stockholders 4MabVax Therapeutics Issues Letter to Stockholders 5MabVax Therapeutics Issues Letter to Stockholders 6MabVax Therapeutics Issues Letter to Stockholders 7MabVax Therapeutics Issues Letter to Stockholders 8MabVax Therapeutics Issues Letter to Stockholders 9MabVax Therapeutics Issues Letter to Stockholders 10MabVax Therapeutics Issues Letter to Stockholders 11MabVax Therapeutics Issues Letter to Stockholders 12MabVax Therapeutics Issues Letter to Stockholders 13
... , EAST NORRITON, Pa. , Aug. 2 Tengion ... has appointed A. Brian Davis to the position of Chief ... Technologies, Inc., a biopharmaceutical company using enzymatic technologies to develop improved protein ... and research personnel at three sites.  , ...
... 2 Reportlinker.com announces that a new market research report is available in ... Asia Pacific Flexible ... , ... This research service ...
... represents one of the most fundamental processes in physics. ... in the summer due to the absorption of light ... or light-emitting diodes that convert electricity into light, we ... lives. Understanding the interactions between individual light particles ...
Cached Biology Technology:Tengion Appoints A. Brian Davis Chief Financial Officer 2Asia Pacific Flexible Alternating Current Transmission Equipment Markets 2Asia Pacific Flexible Alternating Current Transmission Equipment Markets 3Asia Pacific Flexible Alternating Current Transmission Equipment Markets 4Asia Pacific Flexible Alternating Current Transmission Equipment Markets 5Asia Pacific Flexible Alternating Current Transmission Equipment Markets 6Asia Pacific Flexible Alternating Current Transmission Equipment Markets 7One more step on the path to quantum computers 2
(Date:8/5/2015)... 5, 2015 The biosensors market is proving ... penetration into newer sectors, and development of devices resulting ... space has seen the entry of multiple participants each ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) ... of the Global Biosensors Market ( http://www.frost.com/nee9 ), ...
(Date:8/4/2015)... Aug. 04, 2015 ... has announced the addition of the ... and Service), Sub-Segment (Computer Forensics, Network Forensics, ... Types, Service, Vertical and Region - Global ... offering. By Component (Hardware, Software, ...
(Date:8/4/2015)... Aug. 4, 2015  AMRI (NASDAQ: AMRI ) today reported ... 2015. Highlights: , Second quarter contract revenue ... 2014 , Adjusted contract margins of ... $0.22, including a $0.05 decrease in EPS from royalties in the ... million "We are very pleased to present another ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24
... Good news for candy and chocolate lovers: they tend ... waist circumferences, and have decreased levels of risk factors for ... study(1) published in Nutrition Research . The findings ... RD, Louisiana State University Agricultural Center, cautions it is all ...
... from human blood be the key to creating cyborg interfaces? ... an electronic device, such as a robotic limb or artificial ... of biological components. Writing in the International Journal ... describes how a "memristor" can be made using human blood. ...
... Deepwater Horizon oil spill of 2010 devastated the Gulf of ... Conservation Letters reveals that the true impact of ... argues that fatality figures based on the number of recovered ... may be 50 times higher than believed. "The Deepwater ...
Cached Biology News:New study shows you can have your candy and eat it too -- without adverse health effects 2Blood simple circuitry for cyborgs 2Whale and dolphin death toll during Deepwater disaster may have been greatly underestimated 2Whale and dolphin death toll during Deepwater disaster may have been greatly underestimated 3
Applications: Immunohistochemistry, ISH, FISH, CISH....
Applications: Immunohistochemistry, ISH, FISH, CISH....
Polypropylene test tube racks, used in Thermo Forma's line of Test Tube Rack holders...
...
Biology Products: